diagnostics

News

Grail has teamed up with telehealth company Hims & Hers to boost access to its recently filed Galleri blood test for cancer screening.

News

Procyon is hoping to launch a diagnostic test next year that will be able to detect people at risk of pancreatic cancer from a urine sample.

News

Data from a new phase 3 trial of Grail's blood test for multiple cancers show improved efficacy and a lower rate of false alarms than a prior study.

R&D

What makes a biomarker a biomarker?

R&D

We often talk about diagnostics as the gateway to precision medicine. But what happens before and after the test?

R&D

Diagnostic testing in modern medicine remains largely episodic and threshold-based.